Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin versus levofloxacin-based triple therapy for Helicobacter pylori eradication in Nigeria
PACTR202412849496117Phase 4Completed
- Sponsor
- Dr. Igbiti Justice
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of clarithromycin and levofloxacin in Helicobacter pylori infection (2 arms), sponsored by Dr. Igbiti Justice. Primary endpoint: Helicobacter pylori eradication. Started Dec 2023; status: completed.
02
Drugs
clarithromycinlevofloxacin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on PACTR202412849496117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202412849496117.